Entrada Therapeutics, Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax in USD for 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Entrada Therapeutics, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate for 2023.
  • Entrada Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2024 was $19.6M, a 55.3% decline year-over-year.
  • Entrada Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending September 30, 2024 was $215M.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $129M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.